Slit2 is often inactivated in cancers with promoter region CpG (cytosine--phosphate diester—guanine) island hypermethylation and allele loss, including lung, breast, cervical, intestinal, and hepatocellular carcinomas [12,13,14,15]. This evidence concerns the gene SLIT2 and hepatocellular carcinoma.